Navigation Links
Par Pharmaceutical's Karen O'Connor Receives 2013 Cardinal Health Supply Chain Excellence Award
Date:10/24/2013

WOODCLIFF LAKE, N.J., Oct. 24, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. is proud to announce that Karen O'Connor, vice president, national accounts, has received the generic pharmaceutical manufacturer 2013 Cardinal Health Supply Chain Excellence Award.  The award was presented today at Cardinal's annual Business Partners Conference in Columbus, Ohio. 

The Cardinal Health Supply Chain Excellence Award recipient is judged across a variety of metrics specifically targeted at the importance of Cardinal's generic pharmaceutical manufacturer partners.  These metrics recognize actions taken by generic suppliers to enhance service levels and create efficiencies in the supply chain, including execution on new product launches. 

"It is especially gratifying to receive an award from a highly-valued strategic partner," said Renee Kenney, senior vice president generic sales for Par Pharmaceutical.  "Both Karen and Par are honored to be recognized by Cardinal Health for our unwavering commitment to customer service.  Our efforts underscore the importance of this partnership to Par and we are proud of the trust and confidence that Cardinal has placed in us." 

Ms. O'Connor has been responsible for managing the company's relationship with Cardinal Health since joining Par in 2007.  

About Par Pharmaceutical Companies, Inc.  
Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals.  For press release and other company information, visit www.parpharm.com

 


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2a Cellulite Study of Collegenase Clostridium Histolyticum
2. Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
3. CoLucid Pharmaceuticals and ILDONG Pharmaceutical Enter into a Distribution and Supply Agreement for Lasmiditan, a Novel Agent for Acute Migraine
4. Jazz Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 5, 2013
5. Norwich Pharmaceuticals is now Norwich Pharma Services
6. Hanmi Pharmaceuticals to Assign the Rights to Five New Territories to Kinex as Part of the Orascovery Program Strategic Plan
7. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
8. AcelRx Pharmaceuticals to Hold Third Quarter 2013 Financial Results Conference Call and Webcast on November 5, 2013
9. Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013
10. Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
11. DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... As health professionals work to improve their approach to ... is doing more than filling out a survey; in many cases health professionals and ... in health care and research on the importance of active engagement with patients and ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
Breaking Medicine News(10 mins):